Newswise — SAN DIEGO – Early results from a Phase I clinical trial of AT101, a new CAR T cell therapy that uses a distinct binding mechanism to…
Read more First-in-human clinical trial of CAR T cell therapy with new binding mechanism shows promising early responsesNewswise — PHILADELPHIA—For his work discovering the basis for hemoglobin gene switching and applying those insights to develop a therapy for sickle cell disease and other blood diseases,…
Read more Third Elaine Redding Brinster Prize Awarded for Development of Sickle Cell Disease TherapyNewswise — CHICAGO – Over the past decade, the approval of immune checkpoint inhibitors has revolutionized treatment for patients with advanced lung cancer, helping many live longer lives…
Read more Real-World Data Suggests Stopping Immunotherapy after Two Years is Reasonable in Patients with Advanced Lung CancerNewswise — PHILADELPHIA – Two esteemed leaders from the Penn Medicine Abramson Cancer Center and Perelman School of Medicine at the University of Pennsylvania will be honored with…
Read more Two Penn Medicine Abramson Cancer Center Faculty Members Receive Top ASCO AwardsNewswise — PHILADELPHIA—Penn Medicine is launching a new community mental health hub at the Hospital of the University of Pennsylvania — Cedar Avenue (HUP Cedar), co-locating inpatient and…
Read more Penn Medicine to Open New Crisis Response Center as Part of a Unified Mental Health Care Hub at Hospital of the University of Pennsylvania – Cedar AvenueNewswise — PHILADELPHIA— A new approach to the genetic engineering of cells promises significant improvements in speed, efficiency, and reduction in cellular toxicity compared to current methods. The…
Read more Improved Gene Editing Method Could Power the Next Generation of Cell and Gene TherapiesNewswise — PHILADELPHIA— Penn Medicine has received a $9.7 million grant from The Warren Alpert Foundation (WAF) that will fund continuing education efforts for genetic counselors, to ensure…
Read more Penn Medicine Awarded $9.7 Million from The Warren Alpert Foundation for Genetic Counselor Continuing Education EffortsNewswise — PHILADELPHIA – Penn Medicine has partnered with the Howley Foundation and La Salle University to launch the ASPIRE Program at the Hospital of the University of…
Read more Penn Medicine Invests in Future Nurses with ASPIRE Program at the Hospital of the University of PennsylvaniaNewswise — PHILADELPHIA—The U.S. Food and Drug Administration (FDA) has approved the targeted imaging agent Cytalux (pafolacianine) for use in lung cancer surgery. This injectable diagnostic binds to cancerous tissue…
Read more FDA Approves “Glowing Tumor” Imaging Drug to Aid Lung Cancer SurgeryNewswise — NEW ORLEANS – A first-of-its-kind drug known as modakafusp alfa has shown early potential in combating multiple myeloma, a form of bone marrow cancer, in a…
Read more Novel Drug Shows Early Promise in Treating Multiple MyelomaNewswise — NEW ORLEANS – Researchers from the University of Pennsylvania’s Abramson Cancer Center presented preliminary results of an ongoing Phase I clinical trial demonstrating successful re-treatment with…
Read more Penn Medicine Researchers Present Advance in Re-Treatment with CAR T TherapyNewswise — PHILADELPHIA—Adults with a genetic form of childhood-onset blindness experienced striking recoveries of night vision within days of receiving an experimental gene therapy, according to researchers at…
Read more Gene Therapy Rapidly Improves Night Vision in Adults with Congenital Blindness
